Filing Details
- Accession Number:
- 0000920465-17-000036
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-06 16:02:00
- Reporting Period:
- 2017-03-02
- Filing Date:
- 2017-03-06
- Accepted Time:
- 2017-03-06 16:02:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
920465 | La Jolla Pharmaceutical Co | LJPC | Biological Products, (No Disgnostic Substances) (2836) | 330361285 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1663163 | Jennifer Carver | C/O La Jolla Pharmaceutical Company, 10182 Telesis Court, 6Th Floor San Diego CA 92121 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-03-02 | 400 | $34.49 | 2,900 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-03-02 | 300 | $34.45 | 3,200 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-03-02 | 300 | $34.44 | 3,500 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |